Kumho HT Acquires Dynano in 'New Drug Development' Merger

[Asia Economy Reporter Ji Yeon-jin] Kumho HT announced on the 27th that it will absorb and merge its affiliate, Dynona.

The company stated, "As Dynona's new drug development enters clinical trials in earnest, Kumho HT aims to clarify its core businesses not only in the automotive lamp sector but also as a global bio-specialized company, thereby enhancing its external credibility."

The extraordinary general meeting of shareholders for the absorption merger will be held at 12:00 AM on June 10 this year at 1st floor of the annex building, Kumho HT Jangseong Plant, Donghwa-myeon, Jangseong-gun, Jeollanam-do.